IL-22 offers direct support to intestinal epithelial cells by inducing the expression of genes involved in proliferation, wound healing, mucus production, and apoptosis [249], strongly supporting the potential clinical utility of IL-22 as a mucosal healing therapy in IBD [250]. The gene discussed is IL22; the disease is inflammatory bowel disease.